MEDI.OL Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 16892 min ago

@ NOK185.50

Išleistas: 15 bal. 2024 @ 17:25

Grąža: -5.66%

Ankstesnis signalas: bal. 15 - 14:04

Ankstesnis signalas: Pardavimas

Grąža: -3.64 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 17:25):
Our systems believe the stock currently is undervalued by 0.17% compare to its pairs and should correct upwards.

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally...

Stats
Šios dienos apimtis	2 701.00
Vidutinė apimtis	5 636.00
Rinkos kapitalizacija	3.20B
EPS	NOK0 ( 2024-04-24 )
Last Dividend	NOK4.50 ( 2023-04-25 )
Next Dividend	NOK0 ( N/A )
P/E	30.86
ATR14	NOK5.50 (3.09%)

Koreliacija (AI algo v.1.1b): Undervalued: 0.17% NOK178.30 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 1.00 (very strong)

Trumpas: 0.00 (neutral)

Signal:(100) Neutral

Medistim ASA Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
TECH.OL	0.929
ANDF.OL	0.927
KOMPL.OL	0.926
ELIMP.OL	0.915
ASA.OL	0.913
QFUEL.OL	0.909
AUTO.OL	0.909
NEL.OL	0.9
VEI.OL	0.898
BONHR.OL	0.896

10 Labiausiai neigiamai susiję koreliacijos
ODL.OL	-0.917
HAFNI.OL	-0.906
EQNR.OL	-0.904
FROY.OL	-0.898
SBX.OL	-0.889
WWI.OL	-0.876
SNI.OL	-0.861
EIOF.OL	-0.857
AKRBP.OL	-0.857
REACH.OL	-0.855

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Medistim ASA Koreliacija - Valiuta/Žaliavos

0.55
( weak )

0.46
( neutral )

0.00
( neutral )

0.60
( weak )

0.27
( neutral )

-0.27
( neutral )

Medistim ASA Finansinės ataskaitos

Annual	2023
Pajamos:	NOK526.36M
Bruto pelnas:	NOK227.83M (43.28 %)
EPS:	NOK5.68

FY	2023
Pajamos:	NOK526.36M
Bruto pelnas:	NOK227.83M (43.28 %)
EPS:	NOK5.68

FY	2022
Pajamos:	NOK486.26M
Bruto pelnas:	NOK379.78M (78.10 %)
EPS:	NOK6.25

FY	2021
Pajamos:	NOK417.82M
Bruto pelnas:	NOK320.70M (76.76 %)
EPS:	NOK4.99

Financial Reports:

No articles found.

Medistim ASA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK4.50 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)

Medistim ASA Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.90 - Stable (2.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	NOK0.280	2005-04-29
Last Dividend	NOK4.50	2023-04-25
Next Dividend	NOK0	N/A
Payout Date	2023-05-05
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	NOK28.30	--
Avg. Dividend % Per Year	0.96%	--
Score	3.47	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.90
Div. Directional Score	7.98	--

Next Divdend (Est)
(2025-04-04)

NOK4.94 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.47

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2005	NOK0.280	2.98%
2006	NOK0.270	2.05%
2007	NOK0.400	2.42%
2008	NOK0.500	2.63%
2009	NOK0.600	3.90%
2010	NOK0.150	0.64%
2011	NOK0.150	0.60%
2012	NOK1.000	4.35%
2013	NOK1.100	5.50%
2014	NOK0.800	3.48%
2015	NOK1.400	4.67%
2016	NOK1.650	3.06%
2017	NOK1.750	2.27%
2018	NOK2.00	2.78%
2019	NOK2.25	3.37%
2020	NOK2.75	1.42%
2021	NOK3.00	1.20%
2022	NOK3.75	0.96%
2023	NOK4.50	1.93%
2024	NOK0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ALNG.OL	Dividend King	2023-11-27	Quarterly	2	6.60%	7.04
OKEA.OL	Dividend Knight	2023-12-01	Quarterly	3	5.65%	6.86
SALM.OL	Dividend Knight	2023-06-09	Annually	17	2.80%	4.97
BWLPG.OL	Dividend Knight	2023-11-17	Quarterly	11	1.68%	4.46
ELK.OL	Dividend Knight	2023-05-02	Annually	6	6.64%	4.31
BWO.OL	Dividend Knight	2023-11-20	Quarterly	14	0.87%	3.96
ATEA.OL	Dividend Knight	2023-11-20	Annually	16	2.97%	3.45
HAFNI.OL	Dividend Knight	2023-11-23	Semi-Annually	5	1.18%	3.31
AKER.OL	Dividend Knight	2023-11-07	Semi-Annually	20	2.99%	3.13
AUSS.OL	Dividend Knight	2023-05-26	Annually	17	3.23%	2.93

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.197	1.500	6.06	9.08	[0 - 0.5]
returnOnAssetsTTM	0.205	1.200	3.16	3.79	[0 - 0.3]
returnOnEquityTTM	0.272	1.500	8.09	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.15	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.68	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.632	1.500	2.04	3.07	[0.2 - 2]
debtRatioTTM	0.0349	-1.500	9.42	-10.00	[0 - 0.6]
interestCoverageTTM	14.67	1.000	5.68	5.68	[3 - 30]
operatingCashFlowPerShareTTM	6.34	2.00	7.89	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.44	2.00	7.28	10.00	[0 - 20]
debtEquityRatioTTM	0.0443	-1.500	9.82	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.686	1.000	1.903	1.903	[0.2 - 0.8]
operatingProfitMarginTTM	0.250	1.000	7.01	7.01	[0.1 - 0.6]
cashFlowToDebtRatioTTM	6.57	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.041	0.800	6.39	5.12	[0.5 - 2]
Total Score				11.06

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	30.81	1.000	6.99	0	[1 - 100]
returnOnEquityTTM	0.272	2.50	8.77	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.44	2.00	8.19	10.00	[0 - 30]
dividendYielPercentageTTM	2.57	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.34	2.00	7.89	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.220	1.000	7.00	0	[0.1 - 0.5]
Total Score				4.90

Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.